CDC panel backs expanding COVID-19 booster eligibility to all U.S. adults

  • 📰 Reuters
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The U.S. Food and Drug Administration authorized booster doses of COVID-19 vaccines for all adults six months after having been fully vaccinated with the shots from either Pfizer and partner BioNTech, or Moderna

The FDA said its decision was supported by data showing that a third round of shots increased the immune response to the virus in studies of both the Moderna and Pfizer/BioNTech vaccines.

More than 32 million Americans have already received boosters, which had been approved for people in several categories in the United States. Some states in recent days had opened them to all adults ahead of FDA authorization, creating a patchwork of eligibility."The current guidelines - though well intentioned and thoughtful - generate an obstacle to uptake of boosters.

"Our concern is that eligible individuals are not receiving boosters right now," Shah said, noting that no states had voiced opposition to the expanding eligibility. The Biden Administration first proposed boosters for everyone in August, but has made them available in stages as health experts argued there was not enough scientific data to support the need for further vaccination in all groups.

Booster doses of the Pfizer/BioNTech and Moderna vaccines have been available for people who are immunocompromised, those aged 65 and above, and for individuals at high-risk of severe disease or who are regularly exposed to the virus through work or living conditions.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca’s Antibody Cocktail Is 83% Effective At Preventing Covid-19 Symptoms After Six Months, Trial ShowsWhen administered to individuals who hadn’t been exposed to Covid-19, the drug completely eliminated the risk of severe disease or death, the drugmaker said. honestly the vast majority of people dont get their vaccine based on protection. they get their vaccine bec ause they dont want to live with restrictions set up by the state. May God continue to bless you ma'am I never believe trading is going to work out for me because I have lost a lot in different places I know one day they will face the judgment. I really appreciate you for your transparency and trust markdonaldlisaT
Source: Forbes - 🏆 394. / 53 Read more »

AstraZeneca’s Antibody Cocktail Is 83% Effective At Preventing Covid-19 Symptoms After Six Months, Trial ShowsThe antibody cocktail could prove to be an effective tool to protect people who may not develop a good enough immune response after receiving Covid-19 vaccines Did someone say 'cocktail'?
Source: Forbes - 🏆 394. / 53 Read more »